Lifeward (LFWD) EPS (Basic) (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.13% |
| Dec 31, 2025 | -7,900.00% |
| Sep 30, 2025 | 65.52% |
| Jun 30, 2025 | -26.09% |
| Mar 31, 2025 | 98.80% |
| Dec 31, 2024 | -10,865.71% |
| Sep 30, 2024 | 30.00% |
| Jun 30, 2024 | 31.51% |
| Mar 31, 2024 | 97.50% |
| Dec 31, 2023 | -3,217.05% |
| Sep 30, 2023 | -60.00% |
| Jun 30, 2023 | -7.84% |
| Mar 31, 2023 | 74.11% |
| Dec 31, 2022 | -2,088.89% |
| Sep 30, 2022 | -28.57% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | -16.67% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 14.29% |
| Jun 30, 2021 | 12.50% |
| Mar 31, 2021 | 27.27% |
| Dec 31, 2020 | 38.89% |
| Sep 30, 2020 | 18.18% |
| Jun 30, 2020 | 40.54% |
| Mar 31, 2020 | 13.95% |
| Dec 31, 2019 | 6.52% |
| Sep 30, 2019 | 47.73% |
| Jun 30, 2019 | 29.60% |
| Mar 31, 2019 | 38.12% |
| Dec 31, 2018 | 36.68% |
| Sep 30, 2018 | 27.83% |
| Jun 30, 2018 | 15.97% |
| Mar 31, 2018 | 82.21% |
| Dec 31, 2017 | -10,851.85% |
| Sep 30, 2017 | 27.03% |
| Jun 30, 2017 | 5.13% |
| Mar 31, 2017 | 29.09% |
| Dec 31, 2016 | 11.29% |
| Sep 30, 2016 | 16.22% |
| Jun 30, 2016 | -32.14% |
| Mar 31, 2016 | 9.68% |
| Dec 31, 2015 | -16.98% |
| Sep 30, 2015 | -10.42% |
| Jun 30, 2015 | 0.00% |
| Mar 31, 2015 | -4.35% |
| Dec 31, 2014 | -116.37% |
| Sep 30, 2014 | -90.23% |